IL-17A increases TNF-α-induced COX-2 protein stability and augments PGE<inf>2</inf>secretion from airway smooth muscle cells: Impact on β<inf>2</inf>-adrenergic receptor desensitization

Publication Type:
Journal Article
Citation:
Allergy: European Journal of Allergy and Clinical Immunology, 2016, 71 (3), pp. 387 - 396
Issue Date:
2016-03-01
Full metadata record
Files in This Item:
Filename Description Size
MS (Clean version).docAccepted Manuscript Version287 kB
Microsoft Word
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. Background IL-17A plays an important role in respiratory disease and is a known regulator of pulmonary inflammation and immunity. Recent studies have linked IL-17A with exacerbation in asthma and COPD. We have shown that the enzyme cyclooxygenase-2 (COX-2) and its prostanoid products, prostaglandin E2(PGE2) in particular, are key contributors in in vitro models of infectious exacerbation; however, the impact of IL-17A was not known. Methods and Results We address this herein and show that IL-17A induces a robust and sustained upregulation of COX-2 protein and PGE2secretion from airway smooth muscle (ASM) cells. COX-2 can be regulated at transcriptional, post-transcriptional and/or post-translational levels. We have elucidated the underlying molecular mechanisms responsible for the sustained upregulation of TNF-α-induced COX-2 by IL-17A in ASM cells and show that is not via increased COX-2 gene expression. Instead, TNF-α-induced COX-2 upregulation is subject to regulation by the proteasome, and IL-17A acts to increase TNF-α-induced COX-2 protein stability as confirmed by cycloheximide chase experiments. In this way, IL-17A acts to amplify the COX-2-mediated effects of TNF-α and greatly enhances PGE2secretion from ASM cells. Conclusion As PGE2is a multifunctional prostanoid with diverse roles in respiratory disease, our studies demonstrate a novel function for IL-17A in airway inflammation by showing for the first time that IL-17A impacts on the COX-2/PGE2pathway, molecules known to contribute to disease exacerbation.
Please use this identifier to cite or link to this item: